Correlation Between Edgewise Therapeutics and Tevogen Bio

Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Tevogen Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Tevogen Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edgewise Therapeutics and Tevogen Bio Holdings, you can compare the effects of market volatilities on Edgewise Therapeutics and Tevogen Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Tevogen Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Tevogen Bio.

Diversification Opportunities for Edgewise Therapeutics and Tevogen Bio

0.7

Correlation Coefficient

Edgewise Therapeutics  Tevogen Bio

Poor diversification

The 3 months correlation between Edgewise and Tevogen is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Tevogen Bio Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tevogen Bio Holdings and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Tevogen Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tevogen Bio Holdings has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Tevogen Bio go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Tevogen Bio

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Tevogen Bio. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 7.15 times less risky than Tevogen Bio. The stock trades about -0.12 of its potential returns per unit of risk. The Tevogen Bio Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  161.00  in Tevogen Bio Holdings on August 23, 2024 and sell it today you would earn a total of  3.00  from holding Tevogen Bio Holdings or generate 1.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Edgewise Therapeutics  vs.  Tevogen Bio Holdings

Edgewise Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Tevogen Bio Holdings

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tevogen Bio Holdings are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Tevogen Bio displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Edgewise Therapeutics and Tevogen Bio

The main advantage of trading using opposite Edgewise Therapeutics and Tevogen Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Tevogen Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will offset losses from the drop in Tevogen Bio's long position.

The idea behind Edgewise Therapeutics and Tevogen Bio Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.